Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 220 (1-2) , 41-48
- https://doi.org/10.1016/j.jns.2004.02.003
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's diseaseAnnals of Neurology, 1998
- Role of mitochondria in the etiology and pathogenesis of Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASEBrain, 1992
- Is Parkinson's disease a mitochondrial disorder?Journal of the Neurological Sciences, 1992
- Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's diseaseAnnals of Neurology, 1991
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐PhenylpyridiniumJournal of Neurochemistry, 1986
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983